Product category:
Assay kits
News Release from: Neutekbio | Subject: iLite antibeta
Edited by the Laboratorytalk Editorial
Team on 19 October 2007
Rapid quantitation of neutralising
antibodies
Neutekbio introduces its newest product: iLite antibeta for the detection and measurement of neutralising antibodies (NAbs) to Interferon beta (IFNB)
iLite antibeta is based on a conventional gene reporter format, but utilises Neutekbio's patented division-arrested cell technology, the iLite Reporter Cells, which quantitatively respond to IFNB The assay is designed to replace or complement the current time consuming and labour-intensive methods such as cytopathic effect assay (CPE) and MxA
This article was originally published on Laboratorytalk on 20 Jan 2006 at 8.00am (UK)
Related stories
Rapid cytokine bioactivity quantitation
Type I Human Interferon gene reporter assay kit is a simple, rapid and sensitive test for the detection and quantitation of the biological activity of Type 1 IFNs in biological samples
Haematology analyser fills gap in range
With a throughput of 80 samples per hour, this will suit laboratories with workloads of up to 350 samples per day and fills the gap between 60 and 120 sample per hour machines
Innovative new products emphasise R and D
Completely new bench-top analyser combines the latest technological advances and a large test menu with a faster throughput
Assay results are available within approximately 19 hours.
In studies using clinical samples, iLite antibeta demonstrates increased sensitivity in the detection of low-titre positive samples when compared to traditional methods.
The assay can be used for either initial screening of samples, or for a specific NAb titre of positive samples.
No costly and continuous cell culture requirements.
The iLite IFNB sensitive cells are simply thawed when needed, and the assay is ready to go.
There is no need for infectious virus standard preparations which are required by the current time consuming and less reliable tests.
No more unacceptable intra-assay variability seen with more subjective assays.
Neutekbio development and manufacturing facilities operate to ISO13485 quality management systems.
The final product is subjected to rigorous quality release testing, ensuring reproducibility and reliability.
Due to its simple 96 well format and ease of use, the iLite assay is easily transferable to a CRO for clinical investigations, needing a lower level of technical expertise than other techniques available.
• Neutekbio: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
